Drug intelligence / Profile preview

anti-Ly49F antibody

Development stage
Preclinical
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intraperitoneal, Intravenous
01

Overview

Anti-Ly49F antibody is a monoclonal antibody that specifically targets and binds to Ly49F (killer cell lectin-like receptor, subfamily A, member 6; Klra6), an inhibitory receptor expressed on murine natural killer (NK) cells and a subset of CD8+ T cells. In preclinical research, particularly in mouse models of autoimmune diseases such as lupus nephritis, anti-Ly49F antibody is utilized as a depletion reagent to selectively eliminate Ly49F+ CD8+ T cells (the murine homolog of human KIR+ CD8+ T cells). Depletion of this regulatory T-cell subset has been shown to exacerbate autoimmune manifestations, including increased glomerular IgG deposition and elevated serum autoantibodies, thereby demonstrating the protective, suppressive role of Ly49F+ CD8+ T cells in vivo.

Other names
HBF-719HBF719HBF 719anti-Klra6anti-Klra-6anti-Klra 6anti-Klra6 antibodyanti-Klra-6 antibodyanti-Klra 6 antibodyanti-Ly-49Fanti-Ly49Fanti-Ly 49Fanti-Ly-49F antibodyanti-Ly49F antibodyanti-Ly 49F antibody

Beyond the preview

Go deeper on anti-Ly49F antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-Ly49F antibody.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call